Takeda Shareholders Approve Dividends and Directors
Company Announcements

Takeda Shareholders Approve Dividends and Directors

Takeda Pharmaceutical Company (TAK) has released an update.

Takeda Pharmaceutical Company has reported the outcomes of their 148th Ordinary General Meeting of Shareholders held on June 26, 2024, which included the approval of a year-end dividend of 94 yen per share, the election of fourteen directors, and the approval of bonuses for directors. Shareholders voted in favor of all proposals with high approval rates, ensuring the company’s governance and financial decisions are in line with investor expectations.

For further insights into TAK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyStifel bullish on orexin, upgrades Alkermes to Buy
TipRanks Auto-Generated NewsdeskTakeda Pharmaceutical Announces Robust Earnings Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App